Japan Is Suffering From Success As Flattening Cases Hampers Vaccine

Why Is Japan Suffering From Its Own Success In Beatin COVID-19?

SUFFERING FROM SUCCESS – Japan has done a great job in flattening the infection rate of COVID-19. However, this comes at a price.

Due to having lowered infection rates, Japan now has a shortage of patients who could undergo clinical trials for a coronavirus vaccine. Japan’s clinical trials are expected to happen in a month. But, results may be delayed due to the lack of volunteers.

According to an article from ABS-CBN, Tetsuya Nakamura of Gunma University Hospital stated:

Due to the decreasing number of coronavirus infections, we believe it will take some time before clinical research is completed

It’s a pity that Avigan has been approved overseas but not in Japan.

Japan Is Suffering From Success As Flattening Cases Hampers Vaccine
Image from: DW

Previously, Japan encountered a back and forth relationship with the new coronavirus, COVID-19. During its early days with the virus, Japan was lauded for its quick and decisive measures to contain the deadly disease.

READ: 2nd Coronavirus Wave Hits Japanese Island After Lifting Lockdown

However, because of premature lifting of protocols, Japan entered began its 2nd wave of COVID-19 infections. As per the report, this nearly placed the country’s medical system to collapse. But now, merely 60 patients are in serious condition.

Meanwhile, Japanese biotec firm Healios KK announced in April that they planned to add coronavirus patients to its experimental lung therapy trial. But, none enlisted just yet.

According to CFO Richard Kincaid, they were careful to size the cohort due to the lowered number of patients in Japan. As such, he said the company was only looking to enroll around five patients.

Thanks for reading. We aim to provide our readers with the freshest and most in-demand content. Come back next time for the latest news here on Philnews.

Like this article? READ ALSO: Coronavirus Vaccine Effective, Safe In First Human Trial Study Says

Leave a Comment